Package 70000-0014-1

{"route": ["ORAL"], "spl_id": "08f19f3e-edb4-bdd2-e063-6394a90ac626", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0096295137729"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["8aaa82c6-b46b-25c5-e053-2a95a90a3793"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["CARDINAL HEALTH, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "300 TABLET, COATED in 1 BOTTLE (70000-0014-1)", "package_ndc": "70000-0014-1", "marketing_start_date": "20190401"}], "brand_name": "Regular Strength Aspirin", "product_id": "70000-0014_08f19f3e-edb4-bdd2-e063-6394a90ac626", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "70000-0014", "generic_name": "Aspirin", "labeler_name": "CARDINAL HEALTH, INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Regular Strength Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190401", "listing_expiration_date": "20261231"}